Circulating isoprostanes: gate keepers in the route from oxidative stress to vascular dysfunction.
Sauer
Heinrich
H
Wartenberg
Maria
M
D020533:Angiogenesis Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002465:Cell Movement; D042783:Endothelial Cells / Q000378:metabolism*; D006801:Humans; D028421:Isoprostanes / Q000378:metabolism*; D018919:Neovascularization, Physiologic / Q000187:drug effects; D018384:Oxidative Stress; D044244:Receptors, Thromboxane A2, Prostaglandin H2 / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014652:Vascular Diseases / Q000378:metabolism* / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism
D020533:Angiogenesis Inhibitors; D028421:Isoprostanes; D044244:Receptors, Thromboxane A2, Prostaglandin H2; D042461:Vascular Endothelial Growth Factor A